#USA #Genomics #Huntsville #healthŌme #Hannover Re

healthŌme and Hannover Re: Innovators in Genomics-based Insurance

In a groundbreaking achievement, healthŌme®, Inc. and Hannover Re have clinched the 2024 Global Innovation Award for their collaborative efforts in integrating genomics into insurance solutions. This accolade, awarded by esteemed organizations including the International Insurance Society (IIS) and Insurance Thought Leadership (ITL), highlights their commitment to revolutionizing insurance through innovative healthcare solutions.

Darren Rowe, CEO of healthŌme, emphasizes that this success reflects the company's long-standing dedication to personalized healthcare. He noted the crucial support from Hannover Re, stating, "The partnership has greatly enhanced our ability to deliver insurance programs that prioritize proactive health management. Our aim is to reshape how the industry services its clientele."

The integration of genomics into both critical illness and life insurance policies isn't just a technical advancement; it signifies a monumental shift in how personal insurance can cater to individual health needs. healthŌme’s precision health management program equips insurers with tools to elevate their offerings, thereby enhancing consumer engagement and policyholder relationships. By merging cutting-edge living benefit solutions with insurance products, they provide lasting value to insurers and their clients alike.

Steve Najjar, Executive Vice President at Hannover Life Reassurance Company of America, expressed his enthusiasm stating, "This award recognizes our collective efforts to improve cancer treatments. Our partnership leverages genomic technologies to enrich patient care and support healthier lifestyles."

The partnership's reach is even broader, thanks to its collaboration with Chubb. Through the Chubb Workplace Benefits program, healthŌme supports employees via Cancer Advocate Plus. This service includes access to essential precision health insights, personalized medication plans, and specialized cancer management support. According to Alex Faynberg, Division President at Chubb, this program is a model of innovation that combines comprehensive health support with insurance benefits, delivering unrivaled customer value.

Looking ahead to 2025, the initiative will extend its reach to individuals outside the workplace under the name Kadance Precision Health Management Program. This move demonstrates an ongoing commitment to innovation in healthcare and insurance, ensuring that a wider audience gains access to cutting-edge genomic insights.

In conclusion, healthŌme's capabilities as a genomics-focused precision health organization allow it to operate seamlessly at the intersection of healthcare management and insurance. With its in-house genetics lab and commitment to facilitating better health outcomes, healthŌme is poised to redefine the industry landscape, primarily focusing on cancer management. As they continue to innovate, healthŌme remains a pivotal player in the evolving narrative of personalized health insurance.

To learn more about healthŌme and their services, visit healthome.com and connect with them on LinkedIn.